Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker BBIO
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | Maricel Apuli Chief Accounting Officer | BBIO BridgeBio Pharma, Inc. | Sale | 2,000 | $72.85 | $145.7K Sale | Form 4 ↗ |
| Sep 17, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 1,279 | $69.57 | $89.0K Sale | Form 4 ↗ |
| Sep 17, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 8,721 | $69.01 | $601.8K Sale | Form 4 ↗ |
| Aug 19, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 100 | $85.65 | $8,565 Sale | Form 4 ↗ |
| Aug 19, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 1,800 | $84.69 | $152.4K Sale | Form 4 ↗ |
| Aug 19, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 8,100 | $83.86 | $679.3K Sale | Form 4 ↗ |
| Aug 18, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 1,199 | $83.77 | $100.4K Sale | Form 4 ↗ |
| Aug 18, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 14,602 | $82.99 | $1.2M Sale | Form 4 ↗ |
| Aug 18, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 17,279 | $82.21 | $1.4M Sale | Form 4 ↗ |
| Aug 18, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 1,900 | $81.15 | $154.2K Sale | Form 4 ↗ |
| Jul 30, 2026 | Maricel Apuli Chief Accounting Officer | BBIO BridgeBio Pharma, Inc. | Sale | 2,000 | $80.06 | $160.1K Sale | Form 4 ↗ |
| Jul 9, 2026 | Andrea Ellis Director | BBIO BridgeBio Pharma, Inc. | Sale | 17,167 | $84.00 | $1.4M Sale | Form 4 ↗ |
| Jul 9, 2026 | Jennifer E. Cook Director | BBIO BridgeBio Pharma, Inc. | Sale | 112,422 | $90.00 | $10.1M Sale | Form 4 ↗ |
| Jul 9, 2026 | Jennifer E. Cook Director | BBIO BridgeBio Pharma, Inc. | Sale | 36,167 | $84.00 | $3.0M Sale | Form 4 ↗ |
| Jun 24, 2026 | Jennifer E. Cook Director | BBIO BridgeBio Pharma, Inc. | Sale | 37,167 | $70.00 | $2.6M Sale | Form 4 ↗ |
| Jun 23, 2026 | Jennifer E. Cook Director | BBIO BridgeBio Pharma, Inc. | Sale | 2,196 | $68.57 | $150.6K Sale | Form 4 ↗ |
| Jun 23, 2026 | Hannah Valantine Director | BBIO BridgeBio Pharma, Inc. | Sale | 2,196 | $68.57 | $150.6K Sale | Form 4 ↗ |
| Jun 22, 2026 | Hannah Valantine Director | BBIO BridgeBio Pharma, Inc. | Sale | 2,808 | $68.00 | $190.9K Sale | Form 4 ↗ |
| Jun 15, 2026 | Jennifer E. Cook Director | BBIO BridgeBio Pharma, Inc. | Sale | 1,503 | $67.14 | $100.9K Sale | Form 4 ↗ |
| Jun 15, 2026 | Jennifer E. Cook Director | BBIO BridgeBio Pharma, Inc. | Sale | 88,737 | $66.62 | $5.9M Sale | Form 4 ↗ |
| Jun 5, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 4,415 | $68.96 | $304.5K Sale | Form 4 ↗ |
| Jun 5, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 8,437 | $67.88 | $572.7K Sale | Form 4 ↗ |
| Jun 5, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 7,148 | $67.20 | $480.3K Sale | Form 4 ↗ |
| Jun 5, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 4,416 | $68.96 | $304.5K Sale | Form 4 ↗ |
| Jun 5, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 8,437 | $67.88 | $572.7K Sale | Form 4 ↗ |
| Jun 5, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 7,147 | $67.20 | $480.3K Sale | Form 4 ↗ |
| Jun 4, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 450 | $68.27 | $30.7K Sale | Form 4 ↗ |
| Jun 4, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 15,921 | $67.74 | $1.1M Sale | Form 4 ↗ |
| Jun 4, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 1,429 | $66.72 | $95.3K Sale | Form 4 ↗ |
| Jun 4, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 2,200 | $65.72 | $144.6K Sale | Form 4 ↗ |
| Jun 4, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 450 | $68.27 | $30.7K Sale | Form 4 ↗ |
| Jun 4, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 15,921 | $67.74 | $1.1M Sale | Form 4 ↗ |
| Jun 4, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 1,429 | $66.72 | $95.3K Sale | Form 4 ↗ |
| Jun 4, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 2,200 | $65.72 | $144.6K Sale | Form 4 ↗ |
| May 21, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 800 | $70.92 | $56.7K Sale | Form 4 ↗ |
| May 21, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 11,250 | $70.48 | $792.9K Sale | Form 4 ↗ |
| May 21, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 5,072 | $69.22 | $351.1K Sale | Form 4 ↗ |
| May 21, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 6,725 | $68.30 | $459.3K Sale | Form 4 ↗ |
| May 21, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 2,256 | $67.57 | $152.4K Sale | Form 4 ↗ |
| May 18, 2026 | Thomas Trimarchi President and CFO | BBIO BridgeBio Pharma, Inc. | Sale | 3,195 | $65.95 | $210.7K Sale | Form 4 ↗ |
| May 18, 2026 | Thomas Trimarchi President and CFO | BBIO BridgeBio Pharma, Inc. | Sale | 10,456 | $64.82 | $677.8K Sale | Form 4 ↗ |
| May 15, 2026 | Randal W. Scott Director | BBIO BridgeBio Pharma, Inc. | Sale | 200 | $69.12 | $13.8K Sale | Form 4 ↗ |
| May 15, 2026 | Randal W. Scott Director | BBIO BridgeBio Pharma, Inc. | Sale | 1,512 | $68.23 | $103.2K Sale | Form 4 ↗ |
| May 15, 2026 | Randal W. Scott Director | BBIO BridgeBio Pharma, Inc. | Sale | 2,088 | $67.53 | $141.0K Sale | Form 4 ↗ |
| May 15, 2026 | Randal W. Scott Director | BBIO BridgeBio Pharma, Inc. | Sale | 6,200 | $66.69 | $413.5K Sale | Form 4 ↗ |
| May 8, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 950 | $68.35 | $64.9K Sale | Form 4 ↗ |
| May 8, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 5,076 | $67.35 | $341.9K Sale | Form 4 ↗ |
| May 8, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 13,974 | $66.65 | $931.4K Sale | Form 4 ↗ |
| May 8, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 950 | $68.35 | $64.9K Sale | Form 4 ↗ |
| May 8, 2026 | Neil Kumar Chief Executive Officer, Director | BBIO BridgeBio Pharma, Inc. | Sale | 5,077 | $67.35 | $341.9K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:58 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances